A study by Harvard psychiatry professor Joseph Glenmullen, underwritten by plaintiffs' lawyers and previously kept under seal by a court order, says that Glaxo "improperly" counted patients taking placebos during clinical studies.
From 1989 through 1991, Glaxo then submitted information to the FDA that indicated no major difference in risk of suicidal behavior.

Here's a page (click on it to read).
Makes interesting reading, doesn't it?